If you grew up hearing that ADHD was caused by too much sugar, bad parenting, or kids who just needed more discipline, you’re not alone. Those myths have been slow to die. But the science has moved well past them.
ADHD is one of the most researched and well-understood neurodevelopmental conditions we have, and what research keeps confirming, year after year, is that genetics plays a central role. Not the only role, but the dominant one.
Here’s what the evidence actually shows.
What Is ADHD, and Why Does It Matter That It’s Neurodevelopmental?
ADHD, attention-deficit/hyperactivity disorder, is a neurodevelopmental disorder. That word matters. Neurodevelopmental means it originates in how the brain develops, typically beginning before birth and shaping the brain’s wiring from the start. It’s not something that develops in response to a stressful life event or a difficult childhood environment, though those things can certainly make symptoms worse.
ADHD is characterized by persistent patterns of inattention, impulsivity, and hyperactivity that affect daily functioning. Symptoms typically become apparent by age 12, and research shows that between 55 and 66% of people with childhood ADHD continue to experience symptoms into adulthood [1].
At the neurological level, ADHD is closely tied to the brain’s dopamine system, the network responsible for motivation, focus, reward, and impulse control. When dopamine signaling isn’t working efficiently, the effects show up as difficulty sustaining attention, regulating behavior, and managing time. This isn’t a character flaw or a failure of willpower. It’s brain biology [1].
How Genetic Is ADHD?
ADHD is considered one of the most heritable psychiatric conditions known to science. Twin studies comparing identical twins who share 100% of their DNA to fraternal twins (who share roughly 50%) consistently show that genetics accounts for somewhere between 70 and 88% of the variation in ADHD [2].
This doesn’t mean a single “ADHD gene” exists. ADHD is polygenic, meaning hundreds of small genetic variations, many of them related to the brain’s dopamine and norepinephrine systems, accumulate to increase risk [3].
What’s also clear from twin research is that shared environment—things like household income, parenting style, or school quality—contribute very little to ADHD risk once genetics are accounted for.
So, is ADHD a Genetic Disease?
When people hear “genetic disease,” they tend to think of conditions caused by a single faulty gene, like cystic fibrosis or Huntington’s. ADHD doesn’t work that way. It’s better described as a highly heritable neurodevelopmental trait, shaped by hundreds of common genetic variants working together, with some contribution from rare mutations and environmental factors [3][4].
This means ADHD isn’t inevitable even with a strong family history, and it also means it doesn’t require an obvious family history to occur. New genetic variants, prenatal exposures, and other non-inherited factors can all play a role.
What is clear is that ADHD is not caused by diet, parenting, too much screen time, or personal weakness. The brain of someone with ADHD is wired differently, and that wiring has roots that go back to their DNA.
If a Parent Has ADHD, What Are the Odds Their Child Will Have It?
If one parent has ADHD, research suggests a child has roughly a 40 to 50% chance of developing the condition. That’s a substantially higher risk than in the general population, where ADHD affects approximately 5% of children [4].
When both parents have ADHD, the genetic risk increases further. Having ADHD in your family history raises the probability, although it is not always guaranteed. ADHD can appear to skip a generation. Because the condition is influenced by many genes interacting with environmental factors, it’s possible for a parent to carry genetic risk variants without meeting the diagnostic threshold themselves.
ADHD genetics don´t favor one parent over the other. Research consistently shows that maternal and paternal ADHD are equally strong predictors of ADHD in children. There is no identified “ADHD gene” that sits exclusively on the X or Y chromosome [5].
Comprehensive ADHD Treatment in Utah at Maple Mountain
Understanding the genetic basis of ADHD matters because it shifts the frame. ADHD isn’t something a person failed to grow out of or something their parents could have prevented with stricter rules. It’s a legitimate neurobiological condition that responds to legitimate treatment.
At Maple Mountain Recovery, we treat ADHD as part of the whole person, which often means addressing the anxiety, depression, trauma, or substance use that can develop alongside undiagnosed or undertreated ADHD.
Our functional medicine approach also looks at brain health from the inside out: nutrition, inflammation, gut health, and sleep are all factors that influence brain function, including how well someone with ADHD can regulate attention and emotion.
If you or someone you love is navigating ADHD, especially alongside mental health challenges or co-occurring conditions, we’re here to help you understand the full picture through our comprehensive mental health program.
Reach out to our admissions team today to learn more about our options, find out which insurances we accept, or complete our secure online form to verify insurance benefits.
Sources
[1] Faraone, V. et al. (2025). Attention-deficit/hyperactivity disorder (ADHD) in adults: evidence base, uncertainties and controversies. World psychiatry : official journal of the World Psychiatric Association (WPA), 24(3), 347–371.
[2] Plomin, R. (2014). Evidence for shared genetic risk between ADHD symptoms and reduced mathematics ability: a twin study. Journal of child psychology and psychiatry, and allied disciplines, 55(1), 39–48.
[3] Oscar-Berman, M. (2008). Attention-deficit-hyperactivity disorder and reward deficiency syndrome. Neuropsychiatric disease and treatment, 4(5), 893–918.
[4] Larsson, H. (2019). Genetics of attention deficit hyperactivity disorder. Molecular psychiatry, 24(4), 562–575.
[5] Yin, F. (2022). Attention-deficit/hyperactive disorder updates. Frontiers in molecular neuroscience, 15, 925049.
